Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction
Danielle Rasooly, Claudia Giambartolomei, Gina M. Peloso, Hesam Dashti, Brian R. Ferolito, Daniel J Golden, Andréa R. V. R. Horimoto, Maik Pietzner, Eric Farber‐Eger, Quinn S. Wells, Giorgio Bini, Gabriele Proietti, Gian Gaetano Tartaglia, Nicole Kosik, Peter W.F. Wilson, Lawrence S. Phillips, Patricia B. Munroe, Steffen E. Petersen, Kelly Cho, J. Michael Gaziano, Andrew R. Leach, VA Million Veteran Program, John C. Whittaker, Claudia Langenberg, Nay Aung, Yan V. Sun, Alexandre C. Pereira, Juan P. Casas, Jacob Joseph
Topics & Concepts
Ejection fractionOmicsHeart failureScale (ratio)Fraction (chemistry)DrugMedicineComputational biologyInternal medicineCardiologyBiologyPharmacologyBioinformaticsChemistryGeographyChromatographyCartographyCardiovascular Function and Risk FactorsCardiomyopathy and Myosin StudiesHeart Failure Treatment and Management